AzTrials
AzTrials

Osteoarthritis, KneePhase 3NCT06239038

Does Electrocautery Increase Postoperative Pain in Primary Total Knee Arthroplasty

A Phase 3 study testing total knee arthroplasty in people with Osteoarthritis, Knee, run by Police General Hospital, Thailand at 1 site in Thailand.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Total knee arthroplasty (TKA) is a successful treatment for end-stage osteoarthritis of the knee. The main advantages of TKA are to relieve the pain of the knee, improve the knee function, restore lower limb alignment, and improve the quality of life for patients. Read more about this study

Who is it for?
Ages 58 years and olderHealthy volunteers can take part
Conditions the study is for
Osteoarthritis, Knee
What is being tested?
total knee arthroplasty
Could I receive a placebo?
No, everyone receives an active treatment
How many people
132 participants
Where
1 siteThailand
Study dates
11 Oct 2021to 29 Feb 2024
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 58 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Osteoarthritis patient (KL classification gr 2-4)
  • Primary TKA
  • Varus deformity < 20 degree
  • Flexion contracture < 20 degree

Who cannot join

  • Coagulopathy
  • Platelet dysfunction
  • Inflammatory arthritis
  • Revision TKA

Trial locations and contacts

1 site in 1 country.

Thailand1 site
  • Police General Hospital

    Pathum Wan, Bangkok, 10330

Other trials in Thailand

About this study

Official title: Does Electrocautery Increase Postoperative Pain in Primary Total Knee Arthroplasty: A Randomized Controlled Trial

Total knee arthroplasty (TKA) is a successful treatment for end-stage osteoarthritis of the knee. The main advantages of TKA are to relieve the pain of the knee, improve the knee function, restore lower limb alignment, and improve the quality of life for patients. During TKA, some surgeons prefer using a scalpel while others using electrocautery to expose the articular cavity. Whether the use of scalpel can lead to better and faster recovery after the primary TKA is still controversial.

The aim of this study was to compare the clinical outcomes of using the scalpel and the electrocautery in primary TKA

Read the detailed description

A randomized controlled trial of patients underwent primary TKA between October 2021 and October 2023. The groups will be determined by using the computer to generate a randomization lists. A total 132 patients were included with 66 patients in the scalpel group, 66 patients in the electrocautery group. All patients were evaluated using primary outcome : Post-operative Visual Analog Scale (VAS) of pain, secondary outcome: estimated blood loss and Knee Injury and Osteoarthritis Outcome Score (KOOS-JR)

Being tested
total knee arthroplasty
Keywords
Total knee arthroplasty, Electrocautery, Scalpel, Post-operative pain, Pain score
Medical subject headings
Osteoarthritis, Knee, Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • total knee arthroplastyProcedure or surgery

    total knee arthroplasty surgery with Police Arthroplasty joint academy center(PAJAC) Subvastus Approach

Study groups in NCT06239038
Study groupRoleWhat they receive
scalpel groupExperimentalProceed with following step 1. Using electrocautery for stop bleeding at subcutaneous tissue layer 2. In deep layer still use scalpel for Remove anterior cruciate ligament and posterior cruciate ligament 3. Soft tissue removal and synovial tissue removal 4. No patellar denervation
Receives: Procedure: total knee arthroplasty
electrocautery groupExperimentalUsing an electrocautery in following step 1. Stop bleeding at subcutaneous tissue layer 2. Remove anterior cruciate ligament and posterior cruciate ligament 3. Bony mark for further bone cut 4. Patellar denervation 5. Soft tissue removal 6. Synovial tissue removal
Receives: Procedure: total knee arthroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pain (visual analog scale) day 1-4

    measure the Postoperative pain by using visual analog scale from 1 - 10, higher scores means worse outcome

    Measured: postoperative day 1-4

Secondary outcomes (2)
  1. Calculated blood loss

    Calculated blood loss using Mercuruali's formula

    Measured: postoperative day 4

  2. Functional score

    Functional score using KOOS JR score, range from 0 to 100 with a score of 0 indicating total knee disability and 100 indicating perfect knee health

    Measured: follow up 2 weeks, 1,3,6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Feb 2024
  2. Study start11 Oct 2021
  3. Primary completion31 Dec 2023
  4. Study completion29 Feb 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
In electrocautery group, using an electrocautery in following step 1. Stop bleeding at subcutaneous tissue layer 2. Remove anterior cruciate ligament and posterior cruciate ligament 3. Bony mark for further bone cut 4. Patellar denervation 5. Soft tissue removal 6. Synovial tissue removal In scalpel group, proceed with following step 1. Using electrocautery for stop bleeding at subcutaneous tissue layer 2. In deep layer still use scalpel for Remove anterior cruciate ligament and posterior cruciate ligament 3. Soft tissue removal and synovial tissue removal 4. No patellar denervation
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
132 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06239038
Sponsor's protocol ID
PGH protocal
Status last verified
Feb 2024
First submitted
25 Jan 2024
Last updated
6 Feb 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing total knee arthroplasty in people with Osteoarthritis, Knee, run by Police General Hospital, Thailand at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pain (visual analog scale) day 1-4 (time frame: postoperative day 1-4). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in